Oncoinvent

About:

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

Top Investors: Hadean Ventures, MP Pensjon, Watrium AS, Canica, CCS Holding

Description:

Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.

Total Funding Amount:

$60.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Oslo, Oslo, Norway

Founded Date:

2010-08-10

Contact Email:

kvam(AT)oncoinvent.com

Founders:

Roy H. Larsen, Tina Bjørnlund Bønsdorff, Øyvind Sverre Bruland

Number of Employees:

11-50

Last Funding Date:

2021-06-29

IPO Status:

Private

Industries: